Michael addition of nitromethane to non-racemic chiral Cr(CO)3 complexes of ethyl cinnamate derivatives: Stereoselective synthesis of (R)-(-)-baclofen

Tetrahedron Asymmetry

Volumn 11, Issue 9, 2000, Pages 2007-2014

  Baldoli, Clara ^a   Maiorana, Stefano ^a   Licandro, Emanuela ^a   Perdicchia, Dario ^a   Vandoni, Barbara ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CHROMIUM DERIVATIVE; CINNAMIC ACID DERIVATIVE; NITROMETHANE; ORGANOMETALLIC COMPOUND;

ARTICLE; CHIRALITY; CONTROLLED STUDY; DRUG SYNTHESIS; ENANTIOMER; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 0034685794     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0957-4166(00)00123-3     Document Type: Article

References (38)

1. Collins, A. N.; Sheldrake, G. N. Chirality in Industry II; Crosby, J., Ed.; John Wiley & Sons: Chichester, 1997.
2. (a) Davies, S. G.; McCarthy, T. D. In Comprehensive Organometallic Chemistry II; Abel, E. W.; Stone, F. G. A.; Wilkinson, G., Eds.; Pergamon: Oxford, 1995; Vol 12, pp. 1039-1070.
3. (b) Solladié-Cavallo, A. In Advances in Metal-Organic Chemistry; Liebeskind, L. S., Ed.; JAI Press: Greenwich, 1989; Vol. 1, pp. 99-133.
4. (c) Uemura, M. ibid. 1991; Vol. 2, pp. 195-245.
5. Maiorana, S.; Licandro, E.; Capella, L.; Papagni, A.; Perdicchia, D. Pure Appl. Chem. 1999, 71, 1453-1461.
6. (a) Toma, S.; Federic, J.; Gautheron, B. J. Organomet. Chem. 1988, 338, 211-216; Gajda, V.; Toma, S.; Widhalm, M. Monatsh. Chem. 1989, 120, 147-156.
7. (a) Toma, S.; Federic, J.; Gautheron, B. J. Organomet. Chem. 1988, 338, 211-216; Gajda, V.; Toma, S.; Widhalm, M. Monatsh. Chem. 1989, 120, 147-156.
8. (b) Uemura, M.; Oda, H.; Minami, T.; Hayashi, Y. Tetrahedron Lett. 1991, 32, 4561-4568.
9. (c) Uemura, M.; Oda, H.; Minami, T.; Shiro, M.; Hayashi, Y. Organometallics 1992, 11, 3705-3712.
10. (d) Brocard, J.; Mahmoudi, M. A.; Lamiot, J. C.; Baert, F.; Maciejewski, L. A. J. Chem. Soc., Chem. Commun. 1990, 1051-1052.
11. (e) Sarkar, A.; Sur, S.; Ganesh, S.; Puranik V. G. J. Chem. Soc., Perkin Trans. 1 1998, 977-982.
12. (f) Sarkar, A.; Swamy, V. M.; Mandal, S. K. Tetrahedron Lett. 1999, 40, 6061-6064.
13. Sakar reported the addition of nitromethane to racemic 2-arylidene-1-tetralones complexes; the diastereoselections were in the range of 80-90%: Sarkar, A.; Ganesh, S. Tetrahedron Lett. 1991, 32, 1085-1088.
14. B Receptors in Mammalian Function; Bowery, N. G.; Bittinger, M.; Olpe, H. R., Eds.; John Wiley & Sons: Chichester, 1990.
15. (a) Comprehensive Medicinal Chemistry; Hansch, C.; Sammes, P. G.; Taylor, J. B., Eds.; Pergamon Press: New York, 1990.
16. (b) Boyle, I. T.; Johnson, R. V.; Forbes, C. D. Scott. Med. J. 1980, 25-30.
17. (a) Olpe, H. R.; Demiéville, H.; Baltzer, H.; Bencze, W. L.; Koella, W. P.; Wolf, P.; Haas, H. Eur. J. Pharmacol. 1978, 52, 133-136.
18. (b) Caira, M. R.; Clauss, R.; Nassimbeni, L. R.; Scott, L. J.; Wildervanck, A. F. J. Chem. Soc., Perkin Trans. 2 1997, 763-768.
19. (a) Chenevert, R.; Desjardin, M. Can. J. Chem. 1994, 72, 2312-2317.
20. (b) Furstoss, R.; Mazzini, C.; Lebreton, J.; Alphand, V. Tetrahedron Lett. 1997, 38, 1195-1196.
21. (a) Resende, P.; Almeida, W. P.; Coelho, F. Tetrahedron: Asymmetry 1999, 10, 2113-2118.
22. (b) Mashiro, A.; Hashimoto, S. Tetrahedron Lett. 1998, 39, 79-82, and reference 22 cited therein.
23. (c) Brenna, E.; Caraccia, N.; Fuganti, C.; Fuganti, D.; Grasselli, D. Tetrahedron: Asymmetry 1997, 8, 3801-3805.
24. Licandro, E.; Maiorana, M.; Baldoli, C.; Capella, L.; Perdicchia, D. Tetrahedron: Asymmetry 2000, 11, 1-6.
25. Dabard, R.; Jaouen, G. Tetrahedron Lett. 1969, 39, 3391-3394.
26. (a) Davies, S. G.; Goodfellow, C. L. Synlett 1989, 59-62.
27. (b) Davies, S. G.; Goodfellow, C. L. J. Chem. Soc., Perkin Trans. 1 1990, 393-407.
28. (c) Hanaoka, M.; Mukai, C.; Cho, W. J.; Kim, I. J.; Kido, M. Tetrahedron 1991, 47, 3007-3036.
29. (d) Ratni, H.; Kündig, E. P. Org. Lett. 1999, 1, 1997-1999.
30. Sarkar, A.; Mandal, S. K. J. Org. Chem. 1998, 63, 1901-1905.
31. 1H NMR on the crude reaction mixture; diastereoisomeric purity can be increased up to 98% by crystallization.
32. Menincagli, R.; Samaritani, S. Tetrahedron 1996, 52, 1425-1432.
33. Kaberle, H.; Faigle, J. W.; Wilhelm, M. Swiss Patent 1968, 449,046 (Chem. Abstr. 1968, 69, 106273f).
34. Uchimaru, F.; Sato, M.; Kosasayama, E.; Shimizu, M.; Takashi, H. Japanese Patent 1970, 70 16,692 (Chem. Abstr. 1970, 73, 77617w).
35. Solladié-Cavallo, A.; Solladié, G.; Tsamo, E. J. Org. Chem. 1979, 44, 4189-4191.
36. 12a,b in which the nucleophilic attack takes place on the opposite face because of the chelation between the C=O and the trimethylsilyl group.
37. Baker, J. K.; Wall, M. G. J. Med. Chem. 1989, 32, 1340-1348.
38. Mann, A.; Schoenfelder, A.; Le Coz, S. Synlett 1993, 63-64.